AfricaRegulatory
African Pharmaceutical Regulatory Intelligence
AMLODIPINE BESYLATE
111 registrations across 10 African markets— 97 active
Markets with AMLODIPINE BESYLATE
🇹🇿Tanzania
28 registrations
28 active
🇿🇼Zimbabwe
26 registrations
26 active
🇺🇬Uganda
20 registrations
20 active
🇬🇭Ghana
16 registrations
13 active
🇲🇼Malawi
11 registrations
0 active
🇲🇬Madagascar
4 registrations
4 active
🇿🇲Zambia
3 registrations
3 active
🇷🇼Rwanda
1 registration
1 active
🇸🇳Senegal
1 registration
1 active
🇰🇪Kenya
1 registration
1 active
Recent registrations
| Brand / Product | Market | Holder | Status | Expires |
|---|---|---|---|---|
| AMLODIPINE SANDOZ 5MG TABLETS (Each film-coated contains Amlodipine Besylate 5mg) | 🇬🇭Ghana | — | active | Aug 2032 |
| AMLODIPINE SANDOZ 10MG TABLETS (Each film-coated tablet contains Amlodipine Besylate 10mg) | 🇬🇭Ghana | — | active | Aug 2032 |
| AMLODIPINE SANDOZ 10MG TABLETS (Each film-coated tablet contains Amlodipine Besylate 10mg) | 🇬🇭Ghana | — | active | Aug 2032 |
| AMLODIPINE SANDOZ 5MG TABLETS (Each film-coated contains Amlodipine Besylate 5mg) | 🇬🇭Ghana | — | active | Aug 2032 |
| LODIP 5 TABLET; ORAL | 🇿🇼Zimbabwe | N2SA LIMITED | active | Mar 2031 |
| VARINIL 5MG TABLETS Tablet | 🇰🇪Kenya | COSMOS LIMITED | active | Mar 2031 |
| AMODEP 10 TABLET; ORAL | 🇿🇼Zimbabwe | FDC LIMITED | active | Feb 2031 |
| ESEM 5 TABLET; ORAL | 🇿🇼Zimbabwe | MSN LABORATORIES PRIVATE LIMITED | active | Oct 2030 |
| NK AMLODIPINE 5 TABLETS (Each uncoated tablet contains Amlodipine Besylate 5mg) | 🇬🇭Ghana | — | active | Oct 2030 |
| NK AMLODIPINE 10 TABLETS (Each uncoated tablet contains Amlodipine Besylate 10mg) | 🇬🇭Ghana | — | active | Oct 2030 |
| NK AMLODIPINE 10 TABLETS (Each uncoated tablet contains Amlodipine Besylate 10mg) | 🇬🇭Ghana | — | active | Oct 2030 |
| NK AMLODIPINE 5 TABLETS (Each uncoated tablet contains Amlodipine Besylate 5mg) | 🇬🇭Ghana | — | active | Oct 2030 |
| ESEM 2.5 TABLET; ORAL | 🇿🇼Zimbabwe | MSN LABORATORIES PRIVATE LIMITED | active | Oct 2030 |
| AMLOZOR 10 TABLET; ORAL | 🇿🇼Zimbabwe | ZORWAY EXIM PVT LTD | active | Oct 2030 |
| AMLOVAR TABLET; ORAL | 🇿🇼Zimbabwe | VARICHEM PHARMACEUTICALS (PVT) LTD | active | Jan 2030 |
| AMLOVAR TABLET; ORAL | 🇿🇼Zimbabwe | VARICHEM PHARMACEUTICALS (PVT) LTD | active | Jan 2030 |
| AMLOZOR 5 TABLET; ORAL | 🇿🇼Zimbabwe | ZORWAY EXIM PVT LTD | active | Sept 2029 |
| Amdepin 10 tablets Film Coated Tablets | 🇿🇲Zambia | Cadila Pharmaceuticals Limited | active | Sept 2029 |
| CARDIOTEM 5 TABLET | 🇷🇼Rwanda | BAROQUE PHARMACEUTICALS PVT LTD | active | Aug 2029 |
| Lomanor 5 Tablet Uncoated | 🇿🇲Zambia | Viatris South Africa (Pty) Ltd | active | May 2029 |
| Lomanor 10 Tablet Uncoated | 🇿🇲Zambia | Viatris South Africa (Pty) Ltd | active | May 2029 |
| AMLOVASC 5 TABLET; ORAL | 🇿🇼Zimbabwe | NEW AVAKASH INTERNATIONAL | active | Dec 2027 |
| AMLIN-5 TABLET; ORAL | 🇿🇼Zimbabwe | LINCOLN PHARMACEUTICALS LIMITED | active | Dec 2027 |
| AMLOVASC 10 TABLET; ORAL | 🇿🇼Zimbabwe | NEW AVAKASH INTERNATIONAL | active | Dec 2027 |
| AMLODIPINE BESILATE TABLET; ORAL | 🇿🇼Zimbabwe | KOPRAN LTD | active | Dec 2027 |
| AMLOSIN 5 TABLET; ORAL | 🇿🇼Zimbabwe | HETERO LABS LTD | active | Dec 2027 |
| LOMANOR TABLET; ORAL | 🇿🇼Zimbabwe | VIATRIS SOUTH AFRICA (PVT) LTD | active | Dec 2027 |
| CORVADIL-5 TABLET; ORAL | 🇿🇼Zimbabwe | UNICHEM LABORATORIES LIMITED | active | Dec 2027 |
| CORVADIL 10 TABLET; ORAL | 🇿🇼Zimbabwe | UNICHEM LABORATORIES LIMITED | active | Dec 2027 |
| AMLOSIN 10 TABLET; ORAL | 🇿🇼Zimbabwe | HETERO LABS LTD | active | Dec 2027 |
| AMLOZAN ODT-5 TABLET; ORAL | 🇿🇼Zimbabwe | PHARMACEUTICAL AND CHEMICAL DISTRIBUTORS PRIVATE LTD | active | Dec 2027 |
| AMLOCOR-5 TABLET; ORAL | 🇿🇼Zimbabwe | TORRENT PHARMACEUTICALS | active | Dec 2027 |
| AMLOZAN ODT-10 TABLET; ORAL | 🇿🇼Zimbabwe | PHARMACEUTICAL AND CHEMICAL DISTRIBUTORS PRIVATE LTD | active | Dec 2027 |
| NORVASC TABLET; ORAL | 🇿🇼Zimbabwe | VIATRIS HEALTHCARE (PTY) LTD | active | Dec 2027 |
| LOMANOR TABLET; ORAL | 🇿🇼Zimbabwe | VIATRIS SOUTH AFRICA (PVT) LTD | active | Dec 2027 |
| NORVASC TABLET; ORAL | 🇿🇼Zimbabwe | VIATRIS HEALTHCARE (PTY) LTD | active | Dec 2027 |
| CP- AMLODIPINE 5 TABLET; ORAL | 🇿🇼Zimbabwe | COSPHARM INVESTMENTS (PTY) LTD | active | Dec 2027 |
| CP-AMLODIPINE 10 TABLET; ORAL | 🇿🇼Zimbabwe | COSPHARM INVESTMENTS (PTY) LTD | active | Dec 2027 |
| AMLOCOR-10 TABLET; ORAL | 🇿🇼Zimbabwe | TORRENT PHARMACEUTICALS | active | Dec 2027 |
| CORVADIL 10 TABLETS (Each tablet contains Amlodipine Besylate 10mg) | 🇬🇭Ghana | — | active | Oct 2026 |
| CORVADIL 10 TABLETS (Each tablet contains Amlodipine Besylate 10mg) | 🇬🇭Ghana | — | expired | Oct 2026 |
| CORVADIL 10 TABLETS (Each tablet contains Amlodipine Besylate 10mg) | 🇬🇭Ghana | — | active | Oct 2026 |
| TEVRALEX TABLET | 🇬🇭Ghana | NORTHLAND BIOSCIENCE; 545 LANSING AVE STE 2, JACKSON, MI 49201, UNITED STATES | active | Sept 2026 |
| TEVRALEX TABLETS (Each tablet contains Amlodipine Besylate 10mg) | 🇬🇭Ghana | — | expired | Sept 2026 |
| TEVRALEX TABLET | 🇬🇭Ghana | NORTHLAND BIOSCIENCE; 545 LANSING AVE STE 2, JACKSON, MI 49201, UNITED STATES | expired | Sept 2026 |
| TEVRALEX TABLET | 🇬🇭Ghana | NORTHLAND BIOSCIENCE; 545 LANSING AVE STE 2, JACKSON, MI 49201, UNITED STATES | active | Sept 2026 |
| TEVRALEX TABLETS (Each tablet contains Amlodipine Besylate 10mg) | 🇬🇭Ghana | — | active | Sept 2026 |
| AMLODAWA_10 10MG TABLET TABLET | 🇲🇼Malawi | — | expired | Mar 2025 |
| AMLODAWA_5 5MG TABLET TABLET | 🇲🇼Malawi | — | expired | Mar 2025 |
| AMLOWEL_10 10MG TABLET TABLET | 🇲🇼Malawi | — | expired | Mar 2025 |
Showing 50 of 111 registrations. Sign up free to search and export all.
AMLODIPINE BESYLATE in Africa — Regulatory Overview
AMLODIPINE BESYLATE is registered across 10 African markets with 111 total product registrations on file. Data is sourced directly from official national drug regulatory authorities including Tanzania, Zimbabwe, Uganda, Ghana and 6 more. AfricaRegulatory refreshes this data daily from official government sources.
Of the 111 registrations, 97 (87%) are currently active. Regulatory affairs teams use AfricaRegulatory to track registration expiry dates, identify market incumbents, and monitor approval status across African markets without manual monitoring of each national regulator.